Financials
- Market Capitalization 583.63 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.63
ratio cours/chiffre d'affaires
1.53
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2664 | CSTL Castle Biosciences, Inc. - Common stock | 24.23 USD | +0.87% | -1.30% | +18.83% | -1.56% | 734.89 M USD | ||
| 2810 | MYGN Myriad Genetics, Inc. - Common Stock | 6.19 USD | -1.90% | +1.14% | +40.68% | -25.15% | 584.63 M USD | ||
| 3230 | LAB Standard BioTools Inc. - Common Stock | 0.86 USD | +2.38% | -8.51% | +3.61% | -31.20% | 335.46 M USD | ||
| 3282 | PRE Prenetics Global Limited - Class A Ordinary Share | 18.91 USD | -3.42% | +6.48% | -5.17% | +131.74% | 319.09 M USD |